Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Primary Cutaneous Ewing Sarcoma: Case Report and Review of Literature

Jlalia Z1*, Sboui I2, Bouhajja L2, Abid L2, Smida M2, Klibi F2 and Daghfous MS2

1Department of Anatomopathology, Kassab institute of orthopedic surgery, Ksar said, Tunisia

2Department of Kassab institute, University of Tunis, El Manar, Ksar said, Tunisia

*Corresponding Author:
Jlalia Z
Department of Orthopedic and traumatology
Kassab institute of orthopedic surgery
Ksar said 2010 Tunis, Tunisia
Tel: +00 216 95562337
E-mail: sboui_imedk@yahoo.fr

Received date: January 28, 2016; Accepted date: February 04, 2017; Published date: February 10, 2017

Citation: Jlalia Z, Sboui I, Bouhajja L, Abid L, Smida M, et al. (2017) Primary Cutaneous Ewing Sarcoma: Case Report and Review of Literature. J Orthop Oncol 3:115. doi: 10.4172/2472-016X.1000115

Copyright: © 2017 Jlalia Z, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Ewing sarcoma (ES) is a primitive neuroectodermal tumor. It’s usually a primary bone tumor but rarely occurs in the skin and subcutaneous tissues. Current literature reports only a few isolated cases or small series. To date, less than 100 cases have been reported. The diagnosis is made by aspiration cytology, histochemical stains, immunohistochemistry, electron microscopy, cytogenetics and molecular genetics of translocations. Cutaneous ES has better prognosis than primary bone or soft tissue ES with a survival rate of 91% in 10 years. The presence of metastasis is really rare. Currently, no specific recommendations to primitively cutaneous Ewing tumors, these latter are treated as bone Ewing's sarcomas: neoadjuvant chemotherapy, surgery, adjuvant chemotherapy (+/− radiotherapy), and autologous bone marrow transplantation in high risk patients. We report a new case in a 20-yearold female with a lesion in the left elbow.

Keywords

Top